# Vitalant (Harmar - Fox Chapel Area) – FDA Inspection, Aug 22, 2017

Source: https://www.keypedia.com/records/fda_inspections/vitalant-harmar-fox-chapel-area/3e164254-3587-4fa5-ae7b-98d0fe936111
Source feed: FDA_Inspections

> FDA inspection 1024632 of Vitalant (Harmar - Fox Chapel Area), August 22, 2017. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1024632
- Company Name: Vitalant (Harmar - Fox Chapel Area)
- Inspection Date: 2017-08-22
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1231283 - 2024-02-23
- FDA Inspection 1107088 - 2019-09-10
- FDA Inspection 933477 - 2015-07-07
- FDA Inspection 838122 - 2013-06-28
- [FDA Inspection 751770 - 2011-10-28](https://www.keypedia.com/records/fda_inspections/vitalant-harmar-fox-chapel-area/563b1538-a0d6-4e25-9a15-a06ec8de1214)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/travis-r-hunt/a10b358d-80ac-44af-9c9e-761660db1a53)

Company: https://www.keypedia.com/companies/vitalant-harmar-fox-chapel-area/4f35bb4a-b596-4983-a8b9-eec0cd1f21bc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d